AT
Akebia Ther
🇩🇪XSTU.AX9GermanyHealthcare
€0.79EURdown -0.06 (-7.06%)OpenEnd of day5:43 PM
Price€0.79-0.06 (-7.06%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US00972D1054
- CUSIP
- Not reported
Company
- Employees
- 194
- Headquarters
- Cambridge, United States
- Website
- https://www.akebia.com
- CEO
- Mr. John P. Butler MBA
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- -$0.11
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $219.06M+7.52%up year on year
- Net income
- -$29.67M+18.69%up year on year
- Gross margin
- 79.48%+6.76%up year on year
- Free cash flow
- $40.23M+1,677.19%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.